BiomX

BiomX is a pharmaceutical company that researches and develops microbiome-based therapeutics for the treatment of cancer.

Business Model:

Revenue: $0

Employees: 51-200

Detailed BiomX Information

Geographic Data

BiomX headquarters map

Address: 7 Pinhas Sapir St. ,

City: Ness Ziona

State: center district

Zip: 7414002

Country: IL

Financial Info

Stage:

post ipo equity

Raised Last:

$3M

Raised Total:

$56M

Metrics

8,479,867Website Global Rank

304Website Monthly Traffic

Twitter Followers

Description

BiomX is a pharmaceutical company that researches and develops microbiome-based therapeutics for the treatment of cancer.

Contact Phone:

Contact Email:

BiomX went public on 3/13/2019 on the NYSE

Listed Exchange:
NYSE

IPO Date:
3/13/2019

Ticker Symbol:
PHGE

Live

Opened: -/share

EBITDA -
Total Cash -
Total Debt -
Total Revenue -
Total Profit (Gross) -
PE Ratio -
Announced Date Company Transaction Money Raised
Announced Date Transaction Number of Investors Money Raised Lead Investors
1/2022 Post-IPO Equity $0 Cystic Fibrosis Foundation
Cystic Fibrosis Foundation
7/2021 Post-IPO Equity $15M
2/2019 Series B $0 8VC
Handok
SBI Japan-Israel Innovation Fund
Chong Kun Dang Pharmaceutical Corp.
Johnson &a; Johnson Innovation
Takeda Ventures
OrbiMed
Seventure Partners
KB Investment
RM Global Partners
Seventure Partners
Consensus Business Group
8VC
Handok
SBI Japan-Israel Innovation Fund
Chong Kun Dang Pharmaceutical Corp.
Johnson &a; Johnson Innovation
Takeda Ventures
OrbiMed
Seventure Partners
KB Investment
RM Global Partners
Seventure Partners
Consensus Business Group
2/2023 Post-IPO Equity $0 Cystic Fibrosis Foundation
OrbiMed
Cystic Fibrosis Foundation
OrbiMed
Cystic Fibrosis Foundation
OrbiMed
Cystic Fibrosis Foundation
OrbiMed
5/2017 Series A 6 $24M Johnson &a; Johnson Innovation
OrbiMed
Takeda Ventures
Seventure Partners
SBI Japan-Israel Innovation Fund
Mirae Asset
Johnson &a; Johnson Innovation
OrbiMed
Takeda Ventures
2/2019 Series B 11 $32M OrbiMed
Johnson & Johnson Innovation – JJDC, Inc
Takeda Ventures, Inc.
8VC
Seventure Partners
SBI Japan-Israel Innovation Fund
RM Global Partners
BioPharma Investment Fund
Chong Kun Dang Pharmaceutical Corp
KB Investment Co., Ltd
Consensus Business Group
8VC
Handok
SBI Japan-Israel Innovation Fund
Chong Kun Dang Pharmaceutical Corp.
Johnson &a; Johnson Innovation
Takeda Ventures
OrbiMed
Seventure Partners
KB Investment
RM Global Partners
Seventure Partners
1/2022 Post-IPO Equity 1 $3M Cystic Fibrosis Foundation
Cystic Fibrosis Foundation
Announced Date Name Price
12/2017 RondinX

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research